SL4903 CAR-T Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SL4903 CAR-T Therapy, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]